David R. Lally

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

Sunil Patel, David R. Lally, Jason Hsu et al. · Eye · 2023 · 118 citations · Full text

Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration

Ana Bety Enríquez, Caroline R. Baumal, Ashley M. Crane et al. · JAMA Ophthalmology · 2021 · 74 citations · Full text

RETINAL INJURY AFTER INADVERTENT HANDHELD LASER EXPOSURE

Gregory D. Lee, Caroline R. Baumal, David R. Lally et al. · Retina · 2014 · 54 citations